Dainippon Sumitomo raises forecast on Sepracor acquisition
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has increased its sales and profit forecasts for the current fiscal year, reflecting the consolidation of its US acquisition Sepracor.